share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股SEC公告 ·  05/24 13:17

Moomoo AI 已提取核心訊息

Vertex Pharmaceuticals Inc. officer and director, Kewalramani Reshma, is set to sell 1,565 shares of common stock on 05/24/2024, according to a recent filing. The shares, valued at an aggregate market value of $715,205, were originally acquired on the same date through an option granted on 02/06/2019. The transaction will be executed with cash payment. This planned sale follows a significant transaction in the past three months where a total of 15,202 shares were sold, amounting to gross proceeds of $6,795,294.
Vertex Pharmaceuticals Inc. officer and director, Kewalramani Reshma, is set to sell 1,565 shares of common stock on 05/24/2024, according to a recent filing. The shares, valued at an aggregate market value of $715,205, were originally acquired on the same date through an option granted on 02/06/2019. The transaction will be executed with cash payment. This planned sale follows a significant transaction in the past three months where a total of 15,202 shares were sold, amounting to gross proceeds of $6,795,294.
根據最近的一份文件,Vertex Pharmicals Inc.高管兼董事Kewalramani Reshma定於2024年5月24日出售1,565股普通股。這些股票的總市值爲715,205美元,最初是通過2019年6月2日授予的期權於同日收購的。該交易將以現金付款執行。此次計劃出售是在過去三個月進行的一筆重大交易之後進行的,該交易共出售了15,202股股票,總收益爲6,795,294美元。
根據最近的一份文件,Vertex Pharmicals Inc.高管兼董事Kewalramani Reshma定於2024年5月24日出售1,565股普通股。這些股票的總市值爲715,205美元,最初是通過2019年6月2日授予的期權於同日收購的。該交易將以現金付款執行。此次計劃出售是在過去三個月進行的一筆重大交易之後進行的,該交易共出售了15,202股股票,總收益爲6,795,294美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息